All-Case Surveillance of Prizbind®
NCT02946931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1402
Last updated 2022-09-09
Summary
To evaluate safety and effectiveness of Prizbind® for Intravenous Solution 2.5 g under Japanese clinical condition.
Conditions
Interventions
- DRUG
-
Prizbind®
Prizbind®
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-18
- Primary Completion
- 2020-11-03
- Completion
- 2020-11-03
Countries
- Japan
More Related Trials
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
Role of Anti-platelet in Treatment of Acute Ischemic Stroke
NCT03266731 ·Status: UNKNOWN ·Phase: NA
-
Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
NCT02501434 ·Status: SUSPENDED ·Phase: PHASE2
-
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
NCT02687191 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
NCT01222117 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
NCT05198323 ·Status: RECRUITING ·Phase: PHASE2
-
Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy
NCT04693715 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of CN-105 in Subject With Acute Supratentorial Intracerebral Hemorrhage
NCT03711903 ·Status: COMPLETED ·Phase: PHASE2
-
Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy
NCT06437431 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
NCT00126516 ·Status: COMPLETED ·Phase: PHASE4
-
An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke
NCT02229890 ·Status: COMPLETED
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）
NCT05295173 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
NCT06226805 ·Status: RECRUITING ·Phase: PHASE2
-
Safety of Intravenous Thrombolytics in Stroke on Awakening
NCT01643902 ·Status: COMPLETED ·Phase: PHASE2
-
DLBS1033 for the Treatment of Acute Ischemic Stroke
NCT02362984 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist
NCT02866838 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial
NCT03044184 ·Status: UNKNOWN ·Phase: PHASE3
-
DLBS1033 for Acute Ischemic Stroke Patients
NCT02133521 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Intravenous Thrombolysis and NOAC
NCT06749834 ·Status: RECRUITING ·Phase: PHASE3
-
Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan RCT
NCT02419781 ·Status: TERMINATED ·Phase: NA
-
Xarelto [SPAF] Post-marketing Surveillance in Japan
NCT01582737 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke
NCT02928393 ·Status: TERMINATED ·Phase: PHASE2
-
INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)
NCT07341958 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo
NCT05070260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3